• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic study of a novel anti-leukemic agent, G-CSF-Pseudomonas exotoxin fusion protein

Research Project

Project/Area Number 09557082
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Hematology
Research InstitutionThe University of Tokyo

Principal Investigator

TOJO Arinobu  The University of Tokyo, Institute of Medical Science, Lecturer, 医科学研究所, 講師 (00211681)

Co-Investigator(Kenkyū-buntansha) ASANO Shigetaka  The University of Tokyo, Institute of Medical Science, Professor, 医科学研究所, 教授 (50134614)
尾野 雅義  中外製薬育成研究センター, センター長
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥8,200,000 (Direct Cost: ¥8,200,000)
Fiscal Year 1998: ¥4,500,000 (Direct Cost: ¥4,500,000)
Fiscal Year 1997: ¥3,700,000 (Direct Cost: ¥3,700,000)
KeywordsG-CSF / Pseudomonas exotoxin / leukemia
Research Abstract

A chimeric toxin in which the cell surface binding domain of Pseudomonas exotoxin was replaced with mature human granulocyte colony-stimulating factor(G-CSF)was produced in. Escherichia coli, partially purified and tested for its biological activity on a G-CSF-dependent murine myeloid leukemia cell line, NFS60. This fusion protein, termed as G-CSF-PE40, can displace[^<125>I]G-CSF binding to its receptor. After 48 hrs' incubation in the presence of G-CSF, G-CSF-PE40 inhibited protein synthesis and revealed cytotoxicity in NFS60 cells in a concentration dependent manner. The half maximal dose of G-CSF-PE40 for protein synthesis inhibition(ID_<50>)in NFS60 cells was estimated at around 100 pM.Additionally, relatively low concentration of G-CSF-PE40 stimulated DNA synthesis in NFS60 cells after 16 hrs' incubation in the absence of G-CSF, suggesting that G-CSF-PE40 also can transduce a transient mitogenic signal. Next, we placed the signal sequences derived from bacterial alkaline phosphata … More se[phoA]in front of G-CSF, resulting in marked improvement in production of the chimeric toxin, which was secreted into the periplasmic fraction and could be purified without denaturation-refolding steps. Purified G-CSF-toxin was applied to test its activity in normal and leukemic mice. C57/BL6 mice were intraperitoneally injected with about 100 ng of G-CSF-toxin for three consecutive days. These mice showed profound decrease in the number of peripheral neutrophils by the last injection without significant influences on other types of blood cells, but they recovered from neutropenia within 1 week after the last injection. Next, we challenged young-adult female SJLJ mice which were intravenously injected with 10^6 L103 syngeneic myeloid leukemia cells and would die of leukemia within 3 weeks(median : Day 15, n=4). When mice inoculated with L103 cells were simulataneously treated with a single injection of G-CSF-toxin, the survival periods of mice were markedly prolonged(median : Day 30, n=5). These results have encouraged us to apply G-CSF-PE40 to the future treatment of myeloid leukemias. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] Oshima Y,Tojo A,Nino Y Asano S: "Cytotoxic activity of a human grandocyte colony-stimulating factor - Pseudomonas Exotoyin fusion Cortein on murine musloid lcukemia cells" Cancer Research. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Oshima Y,Tojo A,Niho Y,and Asano S.: "Cytotoxic activity of a human granulocyte-colony stimulating factor-Pseudomonas exotoxin fusion protein on murine myeloid leukemia cells." Cancer Research. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Oshima Y,Tojo A,Niho Y,Asano S: "Cytotoxic activity of a human granulocyte colony-stimulating factor-Pseudsmouns Exotoxin fusion protein on murine mysloid lcukemia cells" Cancer Research. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Nishida et al.: "In vitro effects of a recombinant toxin,mSCF-PE40,Targeting c-kit receptors ectopically expressed in small cell lung cancers." Cancer Letters. 113. 153-158 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 東條有仲, 大島康雄: "キメラトキシンによる癌のターゲティング療法" 血液・腫瘍科. 34・3. 217-222 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi